The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Blume-jensen Peter since 2023.
This trader's CIK number is 1950499.
At the time of last reporting, Blume-jensen Peter was the President and CEO of Acrivon Therapeutics, Inc.. (stock ticker symbol ACRV).
Also see all insider trading activities at Acrivon Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | ACRV | 0 | $0 | 0 | $0 | 33,605 | $130,387 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-05-31 | ACRV | Option Ex | 33,605 | 3.88 | 130,387 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Blume-jensen Peter (President and CEO of Acrivon Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.